Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Psychosocial interventions and their effectiveness on quality of life among elderly persons living with HIV in Africa South of the Sahara: Systematic review and meta -analysis protocol.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: San Francisco, CA : Public Library of Science
    • الموضوع:
    • نبذة مختصرة :
      Background: The number of elderly people living with HIV (EPLHIV) has increased significantly as a result of antiretroviral treatment (ART) and this has brought about a variety of psychosocial challenges that have an impact on their quality of life (QoL). Various psychosocial interventions have been tried or implemented in Sub-Saharan Africa (SSA) to improve QoL of EPLHIV. However, there is paucity of data on the types and effectiveness of these interventions. This systematic review, therefore, aims to explore available psychosocial interventions in SSA and their effectiveness in improving the QoL of EPLHIV.
      Methods: We will search PubMed, PsycINFO, LILACS, Cochrane Library, Google Scholar, HINARI, Africa Journals Online, Scopus and Web of Science to retrieve publications on psychosocial interventions implemented to improve QoL of EPLHIV from inception of the identified databases to 31st December 2023 without language restrictions. Also, supplementary sources such as conference proceedings, preprint repositories, databases of dissertations, as well as WHO and governmental databases can be explored for additional studies. For unpublished studies, trial registries and experts would be contacted, and reference lists of retrieved papers will be manually searched. Retrieved studies will be deduplicated using Mendeley and exported to Rayyan. At least two reviewers will independently select studies, extract data and assess the quality of the included studies using validated tools. Dichotomous outcomes data will be assessed and reported as odds ratio (OR) or risk ratio (RR) and for continuous outcomes, mean difference (MD) will be used; all reported with their 95% confidence interval (CI). Heterogeneity will be explored graphically by inspecting the overlapping of CIs and assessed quantitatively using the I2 statistic.
      Expected Outcomes: This systematic review will be the first to rigorously identify psychosocial intervention on QoL of EPLHIV in SSA and assess their effectiveness with the aim to provide regional and country- specific data that will inform the selection and implementation of appropriate and socially acceptable policies across countries in SSA. Key findings of the review are expected to contribute critical evidence on availability, types and effectiveness of psychosocial interventions for improving quality of life of vulnerable elderly persons in SSA living with HIV. Furthermore, the review will explore any variation and possible correlates of psychosocial interventions by age, sex, CD4 count (if available), setting and geographic location within SSA that will provide healthcare professionals with reliable evidence, with the ultimate goal of inspiring countries in SSA to adopt innovative interventions to improve HIV care.
      Trial Registration: Systematic review registration: The systematic review protocol has been registered in the International Prospective Register for Systematic Reviews (PROSPERO), with registration ID CRD42021278218.
      Competing Interests: The authors have declared that no competing interests exist.
      (Copyright: © 2023 Abdulai et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
    • References:
      Drugs. 2013 May;73(7):651-72. (PMID: 23591907)
      J Clin Epidemiol. 2012 Sep;65(9):934-9. (PMID: 22742910)
      J Int AIDS Soc. 2021 Jun;24 Suppl 2:e25748. (PMID: 34164925)
      Clin Exp Immunol. 2017 Jan;187(1):44-52. (PMID: 27198731)
      BMC Med Res Methodol. 2020 May 18;20(1):121. (PMID: 32423382)
      J R Stat Soc Ser C Appl Stat. 2020 Nov;69(5):1091-1119. (PMID: 33132447)
      Syst Rev. 2016 Dec 5;5(1):210. (PMID: 27919275)
      BMJ Open. 2020 Dec 12;10(12):e036988. (PMID: 33310790)
      Health Qual Life Outcomes. 2003 Oct 23;1:59. (PMID: 14613563)
      Clin Psychol Rev. 2016 Jun;46:46-58. (PMID: 27176925)
      BMC Public Health. 2022 Jan 12;22(1):76. (PMID: 35022012)
      Afr J Prim Health Care Fam Med. 2019 May 09;11(1):e1-e11. (PMID: 31170791)
      HIV AIDS (Auckl). 2019 Dec 31;11:387-394. (PMID: 32021481)
      BMC Public Health. 2018 May 21;18(1):644. (PMID: 29783965)
      JMIR Cancer. 2022 Jul 8;8(3):e36255. (PMID: 35802418)
      Int J Ment Health Syst. 2018 Apr 10;12:16. (PMID: 29651302)
      Heart Lung. 2012 Sep-Oct;41(5):469-83. (PMID: 22938627)
      Afr Health Sci. 2021 May;21(Suppl):8-17. (PMID: 34447418)
      AIDS Care. 2022 Jan;34(1):7-15. (PMID: 33663284)
      Nurs Open. 2020 Jun 28;7(5):1299-1312. (PMID: 32802350)
      Qual Life Res. 1996 Oct;5(5):469-80. (PMID: 8973126)
      Int J Infect Dis. 2016 Dec;53:61-68. (PMID: 27756678)
      J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):181-7. (PMID: 21857529)
      Cold Spring Harb Perspect Med. 2012 Jul;2(7):a007070. (PMID: 22762020)
      Implement Sci. 2020 May 24;15(1):37. (PMID: 32448231)
      PLoS One. 2012;7(7):e39471. (PMID: 22848355)
      AIDS Care. 2016;28 Suppl 1:56-9. (PMID: 26888472)
      J Med Internet Res. 2017 May 17;19(5):e172. (PMID: 28526671)
      AIDS Care. 2018 Apr;30(4):493-499. (PMID: 29258342)
      PLoS One. 2018 Nov 29;13(11):e0207005. (PMID: 30496302)
      Br J Anaesth. 2019 Nov;123(5):554-559. (PMID: 31558313)
      Bull World Health Organ. 2010 Nov 1;88(11):847-53. (PMID: 21076566)
      J Affect Disord. 2013 Sep 5;150(2):171-80. (PMID: 23688915)
      J Infect Chemother. 2021 Jul;27(7):949-956. (PMID: 33663931)
      BMJ Open. 2021 Sep 22;11(9):e052810. (PMID: 34551953)
      Syst Rev. 2015 Jan 01;4:1. (PMID: 25554246)
      AIDS Res Ther. 2017 Apr 11;14:22. (PMID: 28400851)
      Cancer. 1996 Feb 1;77(3):576-86. (PMID: 8630968)
      J Aging Health. 2019 Jan;31(1):109-138. (PMID: 28831864)
      J Clin Epidemiol. 2021 Jun;134:178-189. (PMID: 33789819)
      Cells. 2021 Jan 16;10(1):. (PMID: 33467074)
      Can J Nurs Res. 2022 Dec;54(4):371-376. (PMID: 35702010)
      AIDS Behav. 2018 Jan;22(1):9-42. (PMID: 28361453)
      PLoS One. 2017 Aug 4;12(8):e0181960. (PMID: 28783739)
      Curr Opin HIV AIDS. 2016 Sep;11(5):527-536. (PMID: 27367780)
      CMAJ. 2018 Oct 22;190(42):E1253-E1258. (PMID: 30348740)
      BMC Public Health. 2020 Dec 1;20(1):1841. (PMID: 33261566)
      Lancet. 2018 Jul 28;392(10144):312-358. (PMID: 30032975)
    • الموضوع:
      Date Created: 20230920 Date Completed: 20230922 Latest Revision: 20230926
    • الموضوع:
      20240829
    • الرقم المعرف:
      PMC10511069
    • الرقم المعرف:
      10.1371/journal.pone.0291781
    • الرقم المعرف:
      37729324